First derivative spectrophotometric and high-performance liquid chromatographic determination of cinchocaine hydrochloride in presence of its acid degradation product.
Two methods are presented for the determination of cinchocaine HCl in presence of its acid-induced degradation product using first (1D) derivative spectrophotometry and high-performance liquid chromatography. Cinchocaine HCl was determined by measurement of its first derivative amplitude at the zero crossing point of 2-hydroxyquinoline-4-carboxylic acid diethylaminoethylamide as its acid degradation product (at 333.5 nm). The HPLC method depends upon using a mu Bondapak C18 column at ambient temperature with a mobile phase consisting of acetonitrile--0.01 M sodium acetate trihydrate (45:55, v/v) containing 0.06% (w/v) heptane sulphonic acid sodium salt and adjusted to apparent pH 4.5 with acetic acid at a flow rate 2 ml min-1. Quantitation was achieved with UV detection at 254 nm based on peak area. The HPLC method was applied for simultaneous determination of cinchocaine HCl, methylparaben and propylparaben. The two proposed methods were successfully applied to the determination of the cinchocaine HCl in laboratory-prepared mixtures in the presence of its acid degradation product and in cream. Moreover, the proposed methods were utilized to investigate the kinetics of the acid degradation process at different temperatures and the apparent pseudo first-order rate constant, half-life and activation energy calculated.
el-Gindy
A
A
Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt.
Korany
M A
MA
Bedair
M F
MF
D000779:Anesthetics, Local / Q000032:analysis* / Q000737:chemistry / Q000493:pharmacokinetics; D002623:Chemistry Techniques, Analytical / Q000379:methods*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003992:Dibucaine / Q000032:analysis* / Q000737:chemistry / Q000493:pharmacokinetics; D004338:Drug Combinations; D009824:Ointments / Q000737:chemistry; D010226:Parabens / Q000032:analysis; D004364:Pharmaceutical Preparations / Q000737:chemistry; D013053:Spectrophotometry / Q000379:methods*
D000779:Anesthetics, Local; D004338:Drug Combinations; D009824:Ointments; D010226:Parabens; D004364:Pharmaceutical Preparations; C015358:methylparaben; D003992:Dibucaine; C006068:propylparaben